sacituzumab
gilead
['sacituzumab', 'breast', 'mbc', 'tropics-02', 'sacitu, govi']
happening now at #asco23! dr. tolaney ( ) sharing final os data from the tropics-02 study of sacituzumab govitecan in patients with hormone receptor positive/her2-negative (hr+/her2 ) metastatic breast cancer (#mbc). 
Patient-centered care, clinical trials & translational research on breast cancer @DanaFarber and @HarvardMed. Appts: 877-442-3324, Clinical trials: 877-338-7425